Tissuevigilance definitions
Member states shall ensure that there is a system in place to report, investigate, register and transmit information about:
Serious adverse events and reactions which may influence the
quality and safety of tissues and cells and which may be attributed
to the procurement, testing, processing, storage and distribution
of tissues and cells, as well as any serious adverse reaction
observed during or after clinical application which may be
linked to the quality and safety of tissues and cells.
